-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – 200’S Series Novel Combinations (Dopamine Pathway) in Neurodegenerative Diseases
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - 200'S Series Novel Combinations (Dopamine Pathway) in Neurodegenerative Diseases report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. 200'S Series Novel Combinations (Dopamine Pathway) in...
-
Analyst Opinions
Novel and Experimental – Consumer TrendSights Analysis, 2023
Novel and Experimental - Consumer TrendSights Report Overview Novel & experimental is a trend in GlobalData's TrendSights framework, under the sensory & indulgence mega-trend. Aligning with demand for experiences and sensations has been a key driver for the trend. Most categories in packaged consumer goods, foodservice, and retail are showing growth in the Novel & Experimental trend. During 2018-2022, food received the most revenue from trend investment and non-alcoholic beverages showed the highest growth. The "Novel and Experimental" consumer trendsights...
-
Product Insights
Crescent Comm – NOVEL Morrisville Residential Tower – North Carolina
Equip yourself with the essential tools needed to make informed and profitable decisions with our Crescent Comm – NOVEL Morrisville Residential Tower – North Carolina report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Acquire a thorough understanding of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TETRALITE in Seasonal Influenza
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TETRALITE in Seasonal Influenza report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TETRALITE in Seasonal Influenza Drug Details: Tetralite is under development for the...
-
Product Insights
NewLikelihood of Approval Analysis for Refractory Chronic Lymphocytic Leukemia (CLL)
Overview How likely is it that the drugs in Refractory Chronic Lymphocytic Leukemia (CLL) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Refractory Chronic Lymphocytic Leukemia (CLL) Overview Refractory chronic lymphocytic...
-
Product Insights
NewLikelihood of Approval Analysis for Recurrent Glioblastoma Multiforme (GBM)
Overview How likely is it that the drugs in Recurrent Glioblastoma Multiforme (GBM) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Recurrent Glioblastoma Multiforme (GBM) Overview Recurrent glioblastoma multiforme (GBM) refers...
-
Product Insights
NewLikelihood of Approval Analysis for Splenic Marginal Zone B-Cell Lymphoma
Overview How likely is it that the drugs in Splenic Marginal Zone B-Cell Lymphoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Splenic Marginal Zone B-Cell Lymphoma Overview Splenic marginal zone...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATA-2271 in Malignant Pleural Mesothelioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATA-2271 in Malignant Pleural Mesothelioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATA-2271 in Malignant Pleural Mesothelioma Drug Details: ATA-2271 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KFA-115 in Nasopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KFA-115 in Nasopharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KFA-115 in Nasopharyngeal Cancer Drug Details: KFA-115 is under development for the...